Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KRTAP9-10P is a **pseudogene** member of the keratin-associated protein (KAP) gene family, which means it is a nonfunctional copy and does not produce a protein product. KAPs in general play a structural role in hair and wool, cross-linking with keratin intermediate filaments to provide resilience and rigidity to fibers. The KRTAP family is subdivided by amino acid content (high sulfur, ultrahigh sulfur, high glycine/tyrosine), but KRTAP9-10P itself is an annotated pseudogene and does not fulfill a structural or biological role in hair formation. As such, it is not a receptor, enzyme, or any entity typically considered a druggable or therapeutic target. KRTAP9-10P (keratin associated protein 9-10, pseudogene) is a pseudogene without functional protein product, not serving as a therapeutic target, and lacking biological or clinical significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin associated protein 9-10, pseudogene (KRTAP9-10P).